Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 7, 2025
Amerigo Announces Q1-2025 Results & Quarterly Dividend
GlobeNewswire
·
May 7, 2025
Q1-2025 Net Income of $3.3 million Robust EBITDA1 of $15.2 million and Free Cash Flow to Equity1 of $4.8 million 15th Quarterly Dividend of Cdn$.03 Declared $4.6 million Returned through Dividends and Share Buybacks in Q1-2025 VANCOUVER, British Columbia, …
InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trials Multiple near-term catalysts anticipated with the potential to substantially de-risk the Company's pipeline …
OFUYC Exchange Reveals AI Core to Enhance the Security of the Web3 Trading Platform
GlobeNewswire
·
May 7, 2025
GREENWOOD VILLAGE, Colo. , May 07, 2025 (GLOBE NEWSWIRE) -- The rise of Web3 technology has brought unprecedented innovation to decentralized platforms and smart contracts, but it is also accompanied by a large number of security risks and scams. OFUYC …
OFUYC Exchange: AI Core risolve il problema della sicurezza dei contratti intelligenti, migliorando la sicurezza delle piattaforme di trading Web3
GlobeNewswire
·
May 7, 2025
GREENWOOD VILLAGE, Colo. , May 07, 2025 (GLOBE NEWSWIRE) -- L'ascesa della tecnologia Web3 ha portato innovazioni senza precedenti alle piattaforme decentralizzate e ai contratti intelligenti, ma anche numerosi rischi per la sicurezza e truffe. OFUYC …
OFUYC Exchange Introduces AI Intelligent Funds Audit, Strengthening Web3 Asset Security Protection
GlobeNewswire
·
May 7, 2025
GREENWOOD VILLAGE, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- OFUYC Exchange has launched its AI-driven automated fund auditing system, integrated into the OFUYC AI Core backend. This system enables real-time transaction monitoring, risk identification, and …
OFUYC Exchange introduce l'audit intelligente dei fondi basato sull'IA, migliorando la protezione degli asset Web3
GlobeNewswire
·
May 7, 2025
GREENWOOD VILLAGE, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- Recentemente, OFUYC Exchange ha annunciato il lancio ufficiale del suo sistema di audit intelligente automatizzato dei fondi basato sull'IA su OFUYC AI Core, il backend intelligente che consente il …
OFUYC Exchange lancia il programma globale degli ambasciatori dell'ecosistema, guidando la nuova tendenza nell'educazione alla sicurezza Web3
GlobeNewswire
·
May 7, 2025
GREENWOOD VILLAGE, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- Con lo sviluppo del mercato delle criptovalute e la rapida crescita dell'ecosistema Web3, gli utenti principianti si trovano ad affrontare sfide in termini di sicurezza. OFUYC Exchange ha avviato …
OFUYC Exchange Launches Global Eco-Ambassador Program, Leading New Trend in Web3 Security Education
GlobeNewswire
·
May 7, 2025
GREENWOOD VILLAGE, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- As the Web3 ecosystem rapidly grows, novice users face significant security challenges. To address this, OFUYC Exchange has launched a global eco-ambassadors recruitment program aimed at promoting …
Vertex Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
KING OF PRUSSIA, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2025. “Vertex …
Y-mAbs Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma to Include Naxitamab-gqgk (DANYELZA®)
GlobeNewswire
·
May 7, 2025
PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …
Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive
GlobeNewswire
·
May 7, 2025
• Non-Dilutive Financing • Up to US$10 Million Promissory Note Provided by Vantive • If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization • Company to host Corporate Update Call on May 15, 2025 TORONTO, May 07, …
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
GlobeNewswire
·
May 7, 2025
MILAN and NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, today announced a collaboration with Anemocyte, a leading Biotech Manufacturing Organization (BMO) …
Climb Channel Solutions Partners with Smartsheet for Industry-Leading Collaborative Work Management
GlobeNewswire
·
May 7, 2025
EATONTOWN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is excited to be adding Smartsheet, the AI-enhanced …
Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients
GlobeNewswire
·
May 7, 2025
- Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-of-care (SoC) chemotherapy had increased overall survival, progression free survival, and duration of response compared to patients treated with gemcitabine …
Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
GlobeNewswire
·
May 7, 2025
PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2025 Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2025, at 8:00 …
Dayforce Reports First Quarter 2025 Results¹
GlobeNewswire
·
May 7, 2025
Dayforce® recurring revenue, excluding float, of $323 million, up 14%, or 16% on a constant currency basis Total revenue of $482 million, up 12%, and excluding float, up 15%, or 17% on a constant currency basis Net cash provided by operating activities of …
Amarin Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
-- First Quarter 2025 Performance Reflects Contribution from Multiple Revenue Streams Across Geographies, Efforts to Support Strong Balance Sheet and Continued Strategic Execution to Maximize Global Value of VASCEPA®/VAZKEPA® -- -- Nasdaq Listing …
C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 7, 2025
Updated Cemsidomide Multiple Myeloma Data Further Demonstrate Compelling Response Rates at Multiple Doses and Potential for Best-in-Class Profile; 50% ORR Observed at the Highest Dose Level of 100 µg, Including One Patient With a Minimal Residual Disease …
Kymera Therapeutics to Participate in Fireside Chat at the BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 7, 2025
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the …
Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 7, 2025
In line with recent FDA feedback, Seres expects to submit a Phase 2 study protocol to FDA in the coming weeks for SER-155 for the prevention of bloodstream infections (BSIs) in adults undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) for …